Now Reading: Hogan Lovells advises Sartorius Group on a GBP 3.5 million investment in SPARTA Biodiscovery Ltd.
1
-
01
Hogan Lovells advises Sartorius Group on a GBP 3.5 million investment in SPARTA Biodiscovery Ltd.
Hogan Lovells advises Sartorius Group on a GBP 3.5 million investment in SPARTA Biodiscovery Ltd.
Led by Frankfurt partner Dr Christoph Naumann and Birmingham counsel Charles Jemmett, global law firm Hogan Lovells has advised the German Sartorius group on a tranched investment through its investment unit Sartorius Ventures of up to £3.5 million (around €4 million) in UK-based SPARTA Discovery Ltd.
SPARTA Discovery’s analysis platform helps to speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. The SPARTA technology – Single Particle Automated Raman Trapping Analysis – uses spectroscopy to analyze populations of individual nanoparticles quickly and automatically at high throughput – helping to accelerate nanoparticle development and optimize quality control during production. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells.
A team of Frankfurt, London and Birmingham-based lawyers provided legal advice to Sartorius group on all matters relating to the investment agreement.
